Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Aroa Biosurgery has the products and the cash. Can its new US team deliver the next growth phase? Aroa Biosurgery expands its US commercial leadership as Myriad growth accelerates, but FY27 investment must translate into stronger sales productivity. byPallavi MadhirajuJuly 28, 2026